Strand Life Sciences launches Liquid Biopsy test portfolio ‘STRAND LB’ Industry-The Economic Times — April 11, 2017 comments off This STRAND LB test can provide early and precise indication of tumour presence, cancer recurrence, and response to therapy with minimal discomfort to patients.